期刊文献+

禽体内氟苯尼考药动学参数的异速生长分析 被引量:1

Allometric Analysis of Florfenicol Pharmacokinetics Parameters in Five Avian Species
下载PDF
导出
摘要 在收集氟苯尼考在5种禽(鹌鹑、鸽、肉鸡、鸭和火鸡)体内药动学参数的基础上,利用异速生长分析法研究了氟苯尼考的3个主要药动学参数(体清除率(Cl)、稳态表观分布容积(Vss)和消除半衰期(t1/2β))与体重之间的关系。使用了传统的幂函数型异速生长方程来描述药动学参数Y与禽体重W之间的关系,即Y=a×Wb,其中a为幂函数的系数,b为幂函数的指数。研究结果显示:Cl、Vss和t1/2β与W之间的关系式分别为Vss=4.017 7×W-0.508、Cl=1.442 7×W-0.811和t1/2β=3.613 3×W-0.042,相关系数则分别为0.682 5、0.862 5和0.008 6。结果表明,利用异速生长分析能够较准确地预测氟苯尼考在禽体内的药动学参数,特别是Vss和Cl。 This study was to analyze the relationship between pharmacokinetics parameters and body weight (W) for florfenicol using previously reported pharmacokinetics parameters. The parameters of interest: clearance (C1), volume of distribution at steady state (Vss) and half life of elimination (t1/2β) were correla- ted across five avain species, including quail, pigeon, broiler chickens, ducks, and turkeys as a function of W using the conventional allometric equation of Y=a × Wb, where Y is the pharmacokinetics parameter, W is the body weight, a is the allometric coefficient and b is the exponent that describes the relationship between the pharmacokinetics parameter and W. Our estimates (Vss =4. 017 7 × W-0.508, CI= 1. 442 7 × W-0, 811, and t1/2β = 3. 613 3 × W-0.042) indicated that these parameters and W all approximates a linear pow- er relationship with the correlation coefficient (R2) of 0. 682 5, 0. 862 5, and 0. 008 6, respectively. Over- all, the results of this study indicated that it is possible to use allometry analysis to predict pharmacokinet- ies parameters (especially Vss and C1) of florfenicol based on W of avian species.
出处 《动物医学进展》 北大核心 2015年第6期82-85,共4页 Progress In Veterinary Medicine
基金 河南科技大学SRTP项目(2014267)
关键词 氟苯尼考 药动学参数 预测 异速生长分析 avian florfenicol pharmacokinetics parameters prediction allometric analysis
  • 相关文献

参考文献19

  • 1Yohannes S, Hossain M A, Kim J Y, et al. Allometric scaling of marbofloxacin pharmacokinetics~ a retrospective analysis[J]. Pol J Vet Sci, 2014, 17(1):99-103.
  • 2Sy S K, Asin-Prieto E, Derendorf H, et al. Predicting pediatric age-matched weight and body mass index[J]. AAPS J, 2014, 16 (6) :1372-1379.
  • 3Senarathna S M, Batty K T. Interspecies allometric sealing of anti- malarial drugs and potential application to pediatric dosing[J]. An- timicrob Agent Chemother, 2014, 58(10) :6068-6078.
  • 4Huang Q, Riviere J E. The application of allometric scaling princi- ples to predict pharmacokinetic parameters across species[J]. Ex- pert Opin Drug Metab Toxicol, 2014, 10(9) :1241-1253.
  • 5Gebru E, Lee S J, Kim J C, et al. Allometric scaling of orbifloxa- cin disposition in nine mammal species~ a retrospective analysis[J]. J Vet Med Sci, 2011, 73(6)..817-820.
  • 6程培培,杨亚军,刘希望,李剑勇.新型复方氟苯尼考注射液中氟苯尼考HPLC测定方法的建立[J].动物医学进展,2014,35(10):52-56. 被引量:3
  • 7Koc F, Uney K, Ozturk M, et al. Pharmacokinetics of florfenicol in the plasma of Japanese quail[J]. N Z Vet J, 2009, 57(6) :388- 391.
  • 8Ismail M, E1-Kattan Y A. Comparative pharmacokinetics of flor- fenicol in the chicken, pigeon and quail[J]. Br Poult Sci, 2009, 50 (1) :144-149.
  • 9胡顶飞,沈建忠,吴先爱.氟苯尼考静注及肌注在鸡体内药代动力学研究[J].畜牧兽医学报,2002,33(4):384-388. 被引量:19
  • 10Shen J, Hu D, Wu X, et al. Bioavailability and pharmacokinetics of florfenicol in broiler chickens[J]. J Vet Pharmacol Ther, 2003, 26(5) :337-341.

二级参考文献34

  • 1邱银生,吴佳.兽用广谱抗菌药物氟甲砜霉素[J].中国兽药杂志,1996,30(2):47-48. 被引量:53
  • 2丁焕中,曾振灵.生理药动学模型及其在兽医药理学研究中的应用[J].动物医学进展,2007,28(9):55-59. 被引量:8
  • 3Ferraresi C, Lucatello L, Meucci V, et al. Pharmacokinetic/ pharmacodynamic evaluation of the efficacy of flumequine intreating colibacillosis in turkeys[J]. Poult Sei, 2013, 92 (12) 3158-3165.
  • 4Kuroda K, Kijima A, Ishii Y, et al. Flumequine enhances the in vivo mutagenicity of MeIQx in the mouse liver[J]. Arch Toxicol,2013,87(8) : 1609-1619.
  • 5Cornejo J, Lapierre L, Iragueen D, et al. Study of enrofloxacin and flumequine residues depletion in eggs of laying hens after o- ral administration[J]. J Vet Pharmacol Therap, 2012,35 (1) 67-72.
  • 6Corneio J, Lapierre L, Iragueen D, et al. Depletion study of three formulations of flumequine in edible tissues and drug transfer into chicken feathers[J]. J Vet PharmacoI Therap, 2012,34(2) : 168-175.
  • 7Meijer B A, Ceyssens K G, de Jong W T, et al. Bioavailability of flumequine after semisimultaneous administration to veal calves[J]. Pharmac Res,1994,11(1) :117-121.
  • 8Dorrestein G M, Van Gogh H, Buitelaar M N, et al. Clinical pharmacology and pharmacokinetics of flumequine after intrave- nous, intramuscular and oral administration in pigeons (Colum- ba livia)[J]. J Vet Pharmacol Therap,1983,6(4) :281-292.
  • 9Villa R, Cagnardi P, Acocella F, et al. Pharmacodynamics and pharmacokinetics of flumequine in pigs after single intravenousand intramuscular administration[J]. Vet J, 2005,170 ( 1 ) : 101- 107.
  • 10Davies B, Morris T. Physiological parameters in laboratory animals and humans[J]. Pharmae Res, 1993, 10 (7): 1093- 1095.

共引文献21

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部